IBDEI165 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1784,0)
 ;;=UPPER LIMB AMPUTATION STATUS^19^133
 ;;^UTILITY(U,$J,358.4,1785,0)
 ;;=LOWER LIMB AMPUTATION STATUS^7^133
 ;;^UTILITY(U,$J,358.4,1786,0)
 ;;=UNAVAILABILITY OF MED FACILITY CARE^18^133
 ;;^UTILITY(U,$J,358.4,1787,0)
 ;;=CONVALENSCENCE/PALLIATIVE CARE^3^133
 ;;^UTILITY(U,$J,358.4,1788,0)
 ;;=PSYCHIATRIC THERAPY^8^134
 ;;^UTILITY(U,$J,358.4,1789,0)
 ;;=OTHER^7^134
 ;;^UTILITY(U,$J,358.4,1790,0)
 ;;=CASE MANAGEMENT SERVICES^1^134
 ;;^UTILITY(U,$J,358.4,1791,0)
 ;;=HOME HEALTH VISIT^5^134
 ;;^UTILITY(U,$J,358.4,1792,0)
 ;;=COMMUNITY RESIDENTIAL CARE^2^134
 ;;^UTILITY(U,$J,358.4,1793,0)
 ;;=SMOKING/TOBACCO USE CESSATION^9^134
 ;;^UTILITY(U,$J,358.4,1794,0)
 ;;=HEALTH AND BEHAVIOR ASSESSMENT^4^134
 ;;^UTILITY(U,$J,358.4,1795,0)
 ;;=EDUCATION/TRAINING^3^134
 ;;^UTILITY(U,$J,358.4,1796,0)
 ;;=TEAM CONFERENCE^10^134
 ;;^UTILITY(U,$J,358.4,1797,0)
 ;;=ABUSE,NEGLECT, & VIOLENCE^1^135
 ;;^UTILITY(U,$J,358.4,1798,0)
 ;;=ANXIETY DISORDERS^2^135
 ;;^UTILITY(U,$J,358.4,1799,0)
 ;;=BIPOLAR DISORDERS^3^135
 ;;^UTILITY(U,$J,358.4,1800,0)
 ;;=NEUROCOGNITIVE DISORDERS^17^135
 ;;^UTILITY(U,$J,358.4,1801,0)
 ;;=DEPRESSIVE DISORDERS^7^135
 ;;^UTILITY(U,$J,358.4,1802,0)
 ;;=DISSOCIATIVE DISORDERS ^9^135
 ;;^UTILITY(U,$J,358.4,1803,0)
 ;;=FEEDING & EATING DISORDERS^12^135
 ;;^UTILITY(U,$J,358.4,1804,0)
 ;;=EDUCATIONAL/OCCUPATIONAL PROBLEMS^10^135
 ;;^UTILITY(U,$J,358.4,1805,0)
 ;;=GENDER DYSPHORIA^14^135
 ;;^UTILITY(U,$J,358.4,1806,0)
 ;;=HOUSING/ECONOMIC PROBLEMS^15^135
 ;;^UTILITY(U,$J,358.4,1807,0)
 ;;=MEDICATION-INDUCED MOVEMENT DISORDERS^16^135
 ;;^UTILITY(U,$J,358.4,1808,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^19^135
 ;;^UTILITY(U,$J,358.4,1809,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^22^135
 ;;^UTILITY(U,$J,358.4,1810,0)
 ;;=COUNSELING/MEDICAL ADVICE^5^135
 ;;^UTILITY(U,$J,358.4,1811,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^29^135
 ;;^UTILITY(U,$J,358.4,1812,0)
 ;;=PARAPHILIC DISORDERS^21^135
 ;;^UTILITY(U,$J,358.4,1813,0)
 ;;=PERSONALITY DISORDERS^23^135
 ;;^UTILITY(U,$J,358.4,1814,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^135
 ;;^UTILITY(U,$J,358.4,1815,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^135
 ;;^UTILITY(U,$J,358.4,1816,0)
 ;;=RELATIONAL PROBLEMS^25^135
 ;;^UTILITY(U,$J,358.4,1817,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^135
 ;;^UTILITY(U,$J,358.4,1818,0)
 ;;=SEXUAL DYSFUNCTIONS^27^135
 ;;^UTILITY(U,$J,358.4,1819,0)
 ;;=SLEEP-WAKE DISORDERS^28^135
 ;;^UTILITY(U,$J,358.4,1820,0)
 ;;=SUBSTANCE USE DISORDER-ALCOHOL^31^135
 ;;^UTILITY(U,$J,358.4,1821,0)
 ;;=SUBSTANCE USE DISORDER-CANNABIS^33^135
 ;;^UTILITY(U,$J,358.4,1822,0)
 ;;=SUBSTANCE USE DISORDER-HALLUCINOGEN^34^135
 ;;^UTILITY(U,$J,358.4,1823,0)
 ;;=SUBSTANCE USE DISORDER-OPIOID^36^135
 ;;^UTILITY(U,$J,358.4,1824,0)
 ;;=SUBSTANCE USE DISORDER-SEDATIVE/HYPNOTIC^37^135
 ;;^UTILITY(U,$J,358.4,1825,0)
 ;;=SUBSTANCE USE DISORDER-TOBACCO^39^135
 ;;^UTILITY(U,$J,358.4,1826,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^135
 ;;^UTILITY(U,$J,358.4,1827,0)
 ;;=SUBSTANCE USE DISORDER-INHALANT^35^135
 ;;^UTILITY(U,$J,358.4,1828,0)
 ;;=CLINICAL RESEARCH PROGRAM^4^135
 ;;^UTILITY(U,$J,358.4,1829,0)
 ;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^135
 ;;^UTILITY(U,$J,358.4,1830,0)
 ;;=DISRUPTIVE,IMPULSE-CONTROL DISORDERS^8^135
 ;;^UTILITY(U,$J,358.4,1831,0)
 ;;=ELIMINATION DISORDERS^11^135
 ;;^UTILITY(U,$J,358.4,1832,0)
 ;;=GAMBLING DISORDER^13^135
 ;;^UTILITY(U,$J,358.4,1833,0)
 ;;=OTHER MENTAL DISORDERS^20^135
 ;;^UTILITY(U,$J,358.4,1834,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^18^135
 ;;^UTILITY(U,$J,358.4,1835,0)
 ;;=SUBSTANCE USE DISORDER-CAFFEINE^32^135
 ;;^UTILITY(U,$J,358.4,1836,0)
 ;;=SUICIDAL IDEATIONS^41^135
 ;;^UTILITY(U,$J,358.4,1837,0)
 ;;=SUBSTANCE USE DISORDER-UNKNOWN SUBSTANCE^40^135
 ;;^UTILITY(U,$J,358.4,1838,0)
 ;;=SUBSTANCE USE DISORDER-STIMULANTS^38^135
 ;;^UTILITY(U,$J,358.4,1839,0)
 ;;=NEW PATIENT^2^136
 ;;^UTILITY(U,$J,358.4,1840,0)
 ;;=ESTABLISHED PATIENT^1^136
 ;;^UTILITY(U,$J,358.4,1841,0)
 ;;=CONSULTATIONS^3^136
 ;;^UTILITY(U,$J,358.4,1842,0)
 ;;=TELEHEALTH FACILITY FEE^1^137
 ;;^UTILITY(U,$J,358.4,1843,0)
 ;;=A DIAGNOSES^1^138
 ;;^UTILITY(U,$J,358.4,1844,0)
 ;;=D DIAGNOSES^4^138
 ;;^UTILITY(U,$J,358.4,1845,0)
 ;;=E DIAGNOSES^5^138
 ;;^UTILITY(U,$J,358.4,1846,0)
 ;;=F DIAGNOSES^6^138
 ;;^UTILITY(U,$J,358.4,1847,0)
 ;;=I DIAGNOSES^9^138
 ;;^UTILITY(U,$J,358.4,1848,0)
 ;;=K DIAGNOSES^10^138
 ;;^UTILITY(U,$J,358.4,1849,0)
 ;;=M DIAGNOSES^12^138
 ;;^UTILITY(U,$J,358.4,1850,0)
 ;;=N DIAGNOSES^13^138
 ;;^UTILITY(U,$J,358.4,1851,0)
 ;;=P DIAGNOSES^15^138
 ;;^UTILITY(U,$J,358.4,1852,0)
 ;;=R DIAGNOSES^16^138
 ;;^UTILITY(U,$J,358.4,1853,0)
 ;;=S DIAGNOSES^17^138
 ;;^UTILITY(U,$J,358.4,1854,0)
 ;;=T DIAGNOSES^18^138
 ;;^UTILITY(U,$J,358.4,1855,0)
 ;;=V DIAGNOSES^20^138
 ;;^UTILITY(U,$J,358.4,1856,0)
 ;;=X DIAGNOSES^22^138
 ;;^UTILITY(U,$J,358.4,1857,0)
 ;;=C DIAGNOSES^3^138
 ;;^UTILITY(U,$J,358.4,1858,0)
 ;;=W DIAGNOSES^21^138
 ;;^UTILITY(U,$J,358.4,1859,0)
 ;;=B DIAGNOSES^2^138
 ;;^UTILITY(U,$J,358.4,1860,0)
 ;;=G DIAGNOSES^7^138
 ;;^UTILITY(U,$J,358.4,1861,0)
 ;;=H DIAGNOSES^8^138
 ;;^UTILITY(U,$J,358.4,1862,0)
 ;;=L DIAGNOSES^11^138
 ;;^UTILITY(U,$J,358.4,1863,0)
 ;;=O DIAGNOSES^14^138
 ;;^UTILITY(U,$J,358.4,1864,0)
 ;;=U DIAGNOSES^19^138
 ;;^UTILITY(U,$J,358.4,1865,0)
 ;;=Z DIAGNOSES^23^138
 ;;^UTILITY(U,$J,358.4,1866,0)
 ;;=TELEHEALTH FACILITY FEE^1^139
 ;;^UTILITY(U,$J,358.4,1867,0)
 ;;=INFECTIOUS DISEASE^8^140
 ;;^UTILITY(U,$J,358.4,1868,0)
 ;;=NEOPLASMS^10^140
 ;;^UTILITY(U,$J,358.4,1869,0)
 ;;=HEMATOLOGY/ENDOCRINE^6^140
 ;;^UTILITY(U,$J,358.4,1870,0)
 ;;=MENTAL HEALTH^9^140
 ;;^UTILITY(U,$J,358.4,1871,0)
 ;;=NEUROLOGY^11^140
 ;;^UTILITY(U,$J,358.4,1872,0)
 ;;=OPHTHALMOLOGY^12^140
 ;;^UTILITY(U,$J,358.4,1873,0)
 ;;=GI^5^140
 ;;^UTILITY(U,$J,358.4,1874,0)
 ;;=CARDIOLOGY^2^140
 ;;^UTILITY(U,$J,358.4,1875,0)
 ;;=HERNIA^7^140
 ;;^UTILITY(U,$J,358.4,1876,0)
 ;;=GENITOURINARY^4^140
 ;;^UTILITY(U,$J,358.4,1877,0)
 ;;=SKIN^16^140
 ;;^UTILITY(U,$J,358.4,1878,0)
 ;;=ENT^3^140
 ;;^UTILITY(U,$J,358.4,1879,0)
 ;;=RHEUMATOLOGY/ORTHO^14^140
 ;;^UTILITY(U,$J,358.4,1880,0)
 ;;=RESPIRATORY^13^140
 ;;^UTILITY(U,$J,358.4,1881,0)
 ;;=SIGNS/SYMPTOMS/HX OF^15^140
 ;;^UTILITY(U,$J,358.4,1882,0)
 ;;=VASCULAR^17^140
 ;;^UTILITY(U,$J,358.4,1883,0)
 ;;=ANTICOAGULATION^1^140
 ;;^UTILITY(U,$J,358.4,1884,0)
 ;;=MD/NP/PA ^1^141
 ;;^UTILITY(U,$J,358.4,1885,0)
 ;;=RN/LPN/SW/OTH HC PROF^2^141
 ;;^UTILITY(U,$J,358.4,1886,0)
 ;;=TELEPHONE DIAGNOSES^1^142
 ;;^UTILITY(U,$J,358.4,1887,0)
 ;;=CHEST WALL AND NECK^1^143
 ;;^UTILITY(U,$J,358.4,1888,0)
 ;;=THORACIC^2^143
 ;;^UTILITY(U,$J,358.4,1889,0)
 ;;=OTHER PROCEDURES^3^143
 ;;^UTILITY(U,$J,358.4,1890,0)
 ;;=NEW PATIENT^2^144
 ;;^UTILITY(U,$J,358.4,1891,0)
 ;;=ESTABLISHED PATIENT^1^144
 ;;^UTILITY(U,$J,358.4,1892,0)
 ;;=CONSULTATIONS^3^144
 ;;^UTILITY(U,$J,358.4,1893,0)
 ;;=POST-OP FOLLOW-UP^4^144
 ;;^UTILITY(U,$J,358.4,1894,0)
 ;;=GENERAL SIGNS & SYMPTOMS^3^145
 ;;^UTILITY(U,$J,358.4,1895,0)
 ;;=AFTERCARE POST-OP^1^145
 ;;^UTILITY(U,$J,358.4,1896,0)
 ;;=POST-OP COMPLICATIONS^5^145
 ;;^UTILITY(U,$J,358.4,1897,0)
 ;;=CARDIOVASCULAR^2^145
 ;;^UTILITY(U,$J,358.4,1898,0)
 ;;=RESPIRATORY^7^145
 ;;^UTILITY(U,$J,358.4,1899,0)
 ;;=NEOPLASM^4^145
 ;;^UTILITY(U,$J,358.4,1900,0)
 ;;=PRE-OP^6^145
 ;;^UTILITY(U,$J,358.4,1901,0)
 ;;=NEW PATIENT^2^146
 ;;^UTILITY(U,$J,358.4,1902,0)
 ;;=ESTABLISHED PATIENT^1^146
 ;;^UTILITY(U,$J,358.4,1903,0)
 ;;=POST-OP (GLOBAL)^3^146
 ;;^UTILITY(U,$J,358.4,1904,0)
 ;;=JOINT INJECTIONS^15^147
 ;;^UTILITY(U,$J,358.4,1905,0)
 ;;=TENDON INJECTION^26^147
 ;;^UTILITY(U,$J,358.4,1906,0)
 ;;=SKIN PROCEDURES^24^147
 ;;^UTILITY(U,$J,358.4,1907,0)
 ;;=ADMINISTRATION OF INJ MEDICATIONS^2^147
 ;;^UTILITY(U,$J,358.4,1908,0)
 ;;=EKG^11^147
 ;;^UTILITY(U,$J,358.4,1909,0)
 ;;=NOSEBLEEDS^16^147
